NEXUS Biosystems, Inc. Announces Closing Of Its Series A Financing And Relocation

POWAY, Calif.--(BUSINESS WIRE)--Dec. 20, 2005--NEXUS Biosystems(TM), Inc. (NEXUS), a new life sciences technology company formed by a recent management buyout, announced the closing of its Series-A financing and relocation to its new 37,000 square foot corporate headquarters in Poway, California. As a provider of innovative automation solutions, software applications, consumables and services to pharmaceutical, biotech, agrichemical and academic research laboratories worldwide, NEXUS is pleased to have attracted a strong group of Series A investors. This group is led by John Lillig, NEXUS CEO and Rob Neeper, NEXUS VP Operations, and includes Dr. Mark Chee who also serves on the NEXUS Board of Directors, and Paxanic Tazoka, LTD.